Zeta Toxoplasma gondii Antibody. Zeta’s polyclonal antibody recognizes Toxoplasma gondii, a single-celled parasite, causes the disease toxoplasmosis. The life cycle of Toxoplasma gondii includes two phases: the intestinal (or enteroepithelial) and extraintestinal phases. The intestinal phase of Toxoplasma gondii produces oocysts and occurs only in wild and domesticated cats. The extra-intestinal phase of Toxoplasma gondii occurs in all infected animals and produces tachyzoites (actively proliferating trophozoites) and, eventually, bradyzoites (slowly growing trophozoites) or zoitocysts. Toxoplasma gondii infects tissue of the gastrointestinal tract, brain and lung in immunocompromised patients.
Zeta Corporation is a leader in recombinant monoclonal IVD antibodies for immunohistochemistry (IHC) offering 400+ tumor and tissue specific relevant products developed by a pathologist for pathologists. Visit Precision Recombinant Antibodies – IVD Antibodies – About Zeta Corporation (zeta-corp.com) to learn more about Zeta Corporation.